A - Human Necessities – 61 – M
Patent
A - Human Necessities
61
M
A61M 16/00 (2006.01) A61M 35/00 (2006.01)
Patent
CA 2605207
A method of topically treating the respiratory tract of a mammal with nitric oxide exposure includes the steps of providing a source of nitric oxide containing gas and delivering the nitric oxide containing gas nasally to the upper respiratory tract of the mammal. Also provided are several designs for a nasal delivery device for the controlled nasal deliver the nitric oxide containing gas.
La présente invention se rapporte à une méthode destinée à traiter de manière topique les voies respiratoires d'un mammifère, par une exposition à du monoxyde d'azote. La méthode selon l'invention consiste à fournir une source d'un gaz contenant du monoxyde d'azote, et à administrer ledit gaz contenant du monoxyde d'azote par voie nasale aux voies respiratoires supérieures du mammifère. L'invention a également trait à plusieurs modèles de dispositifs d'administration nasale permettant l'administration nasale contrôlée du gaz contenant du monoxyde d'azote.
Miller Christopher C.
Stenzler Alex
Osler Hoskin & Harcourt Llp
Pulmonox Technologies Corporation
Sensormedics Corporation
LandOfFree
Nitric oxide decontamination of the upper respiratory tract does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitric oxide decontamination of the upper respiratory tract, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide decontamination of the upper respiratory tract will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2058535